Development of novel therapeutics for the treatment of human glioblastoma

Project: Research project

Project Details

Description

Goals are to evaluate the novel GSK-3 inhibitor 9-ING-41 in combination with a panel of chemotherapeutic drugs used clinically to treat recurrent glioblastoma.
StatusFinished
Effective start/end date1/1/1612/31/17

Funding

  • Northwestern Memorial Hospital (NMH Master #7/Exhibit B.8)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.